We have screened 78 genital tract tumours from Italian female patients for the presence of human papillomavirus type 16 (HPV-16) and HPV-18 DNA. Dot and Southern blot hybridization experiments revealed that DNA sequences of HPV-16 and/or HPV-18 are present in 66~ of tumour samples. HPV-18 was detected in 80~o of vulvar carcinomas. In these tumours the integration of HPV-18 DNA seems to occur in the E 1/E2 region of the virus genome with long deletions in almost all samples. The invariable retention of the non-coding region and the E6/E7 open reading frames suggests that the integration event and the possible expression of these sequences could play a role in some stages of cellular transformation.
Presence of Human Papillomavirus

SUMMARY
We have screened 78 genital tract tumours from Italian female patients for the presence of human papillomavirus type 16 (HPV-16) and HPV-18 DNA. Dot and Southern blot hybridization experiments revealed that DNA sequences of HPV-16 and/or HPV-18 are present in 66~ of tumour samples. HPV-18 was detected in 80~o of vulvar carcinomas. In these tumours the integration of HPV-18 DNA seems to occur in the E 1/E2 region of the virus genome with long deletions in almost all samples. The invariable retention of the non-coding region and the E6/E7 open reading frames suggests that the integration event and the possible expression of these sequences could play a role in some stages of cellular transformation.
There is increasing evidence that at least some types of papillomavirus are involved in the development of genital tract tumours. Human papillomavirus type 16 (HPV-16) and HPV-18 have been found in 60 to 80~ of cervical carcinomas and other tumours of the genital tract (Boshart et al., 1984; Crum et al., 1985 ; Dfirst et al., 1983 ; Scholl et al., 1985; Tsunokawa et al., 1986) . HPV DNA sequences are present mainly as free DNA molecules in intraepithelial neoplasia (Crum et al., 1985 ; Diirst et al., 1985) and as sequences integrated in the host genome in invasive carcinomas (Lehn et al., 1985; Matsukura et al., 1986; Schneider-Maunoury et al., 1987) .
We report here the incidence of HPV-16 and HPV-18 DNA in genital tumours of Italian patients and the analysis of the integration pattern of HPV-18 sequences in cellular DNA from vulvar carcinomas, a group of neoplasias occurring at low incidence but with high mortality.
The screening was performed on genital tumour biopsies kept frozen after surgical removal. DNA samples extracted from 78 neoplasias of the female genital tract were tested by dot blot hybridization with HPV probes in conditions of high stringency (T m -18 °C) as previously reported (Venuti et al., 1987) . Forty-nine of 74 genital carcinomas were found to contain HPV-16 and/or HPV-18 DNA sequences while only one adenocarcinoma gave positive results for HPV-16 hybridization (Table 1) . Although HPV-16 DNA is found twice as frequently as HPV-18 DNA in genital tumours, the latter was found with a higher incidence in vulvar carcinomas (Table 2 ). This high incidence of HPV-18 in vulvar carcinomas has not been reported before. The number of vulvar carcinomas analysed in this study is small, and therefore it is not possible to say whether this association reflects geographical differences in the distribution of virus types or some biological property of HPV-18. Cole & Danos (1987) have shown that HPV-18 is less closely related evolutionarily to the other oncogenic papillomaviruses HPV-16 and HPV-33. As shown in Tables 1 and 2 there is no correlation between the histological type of neoplasia and type of HPV; even an adenocarcinoma was positive for HPV-16 DNA sequences, as already reported by other authors (Fukushima et al., 1985; Tsunokawa et al., 1986) . Normal tissue biopsies excised from outside the tumour site were negative ( Table 2 ), suggesting that the presence of viral DNA is limited to the neoplastic areas at least in this study. To evaluate the physical state of HPV-18 DNA in this group of tumours, DNA samples extracted from vulvar carcinomas were further analysed by BamHI digestion, which cleaves the prototype HPV-18 DNA into two fragments of 6.81 and 1.047 kb (Schwarz et al., 1985) . No samples showed the distinct BamHI pattern of HPV-18 (Fig. 1) . The intensities of the bands hybridizing to the HPV-18 probe varied in different samples. The copy number of HPV DNA sequences was estimated to be approx. 10 to 100 copies per haploid genome, and the size of the BamHI fragments also differed in different samples; this was consistent with the possible integration of the virus sequences in the host genome.
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To verify this hypothesis DNA samples were also processed by two-dimensional agarose gel electrophoresis to ascertain whether viral episomal forms were still present (Johnson & Grossmann, 1977; Wettstein & Stevens, 1982) . In these experiments the cellular DNA was digested with HindIII which does not cut the HPV-18 genome, to ensure good electrophoretic separation; hybridization and washing were carried out at low stringency to increase the sensitivity. A two-dimensional gel electrophoresis profile of a vulvar squamous cell carcinoma DNA sample is shown in Fig. 2 . No distinct spots separate from the track of linear DNA were detected in the sample, indicating the absence of viral episomes. The same result was obtained with the other vulvar carcinomas examined (data not shown). Therefore HPV-18 DNA integration into the host genome seems to occur at very high frequency in these tumours. These data strongly support the hypothesis that the integration of HPV DNA into the host genome takes place in the invasive carcinoma (Choo et al., 1987; Schneider-Maunoury et al., 1987) . To ascertain whether a region of HPV-18 genome was consistently retained during integration, as has been found for HPV-16 (Choo et al., 1987) , hybridization experiments with subgenomic probes of HPV-18 DNA were done as shown in Fig. 3 . Owing to the low amount of DNA extracted from small biopsies we hybridized the same dot blot filter with three different subgenomic probes. The filter was first hybridized with 32p-labelled B a m H I -B a m H I (1.047 kb) fragment containing the non-coding region (NCR) (probe A), and after removal of the probe was rehybridized with a mixture of 32p-labelled B a m H I -E c o R I (2.323 kb) fragment containing the E6 and E7 open reading frames (ORFs) (probe B) and biotin-labelled E c o R I -B a m H I fragment (4-487 kb) containing the remainder of the viral genome (probe C). Hybridization of probe C was monitored by reaction with alkaline phosphatase-streptavidin conjugate and staining with 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and nitro blue tetrazolium (NTB) and that of probes A and B by autoradiography. In all vulvar carcinoma DNAs we found sequences hybridizing with the HPV-18 fragments corresponding to the NCR and the E6/E7 ORFs (Fig. 3) . Only two samples gave positive results with the fragment corresponding to the remaining portion of the HPV genome. These findings are not due to differences in the sensitivity of the probes because the same experiment done with biotin-labelled probe B and radioactively labelled probe C gave the same results (data not shown). The hybridization experiments with the subgenomic probes suggest that virus integration could occur in a region downstream of the E6/E70RF and most probably within the E 1/E2 region as found for HPV-16 in cervical carcinomas (Choo et al., 1987; Schneider-Maunoury et al., 1987) and in cell lines derived from them (Baker et al., 1987; Smotkin & Wettstein, 1986) . In all but two vulvar tumour DNAs the integration caused a long deletion in the virus sequences around the break point as demonstrated by lack of hybridization with the subgenomic fragment corresponding to the region between the E2 and L2 ORFs; however, we cannot exclude the possibility that a small part of this region was present. The retention of E6/E7 ORF sequences in all tested tumours Table 2 . The genomic map of prototype HPV-18 is represented on the top of the figure together with the position of the probes used in the hybridization experiment.
together with the transforming activity of this sequence in several cell lines (Yasumoto et al., 1986; Storey et al., 1988 ; Kanda et al., 1988) suggests that these sequences may contain potential oncogenes and be essential in some stages of cellular transformation and/or maintenance of the transformed state. At the same time the presence of the NCR could affect other mechanisms of cell transformation either by insertional cis-or trans-activation of some cellular protooncogenes and/or by continuous expression of the E6/E7 ORF sequences (Dfirst et al., 1987; Popescu et al., 1987) . To clarify this point work is now in progress to detect the expression level of HPV sequences and of cellular oncogenes in a large number of tumours.
